The Latin America, Middle East and Africa Human Milk Oligosaccharides Market would witness market growth of 25.5% CAGR during the forecast period (2023-2030).
One of the primary drivers of the HMOs is the growing understanding of the nutritional significance of these complex sugars in human breast milk. HMOs serve as prebiotics, promoting the growth of beneficial gut bacteria in infants. This, in turn, contributes to developing a healthy immune system and lowering the risk of infections. Research has also suggested that HMOs support cognitive development, further elevating their importance in infant nutrition. As a result, HMOs have gained attention as a critical component contributing to the health and well-being of breastfed infants.
Technological advancements in biotechnology have played a pivotal role in the development and commercialization of HMOs. Researchers and companies are investing in innovative production methods, such as microbial fermentation and enzymatic synthesis, to produce HMOs on a larger scale. These advancements not only contribute to the accessibility of HMOs but also open doors to customization, allowing for the creation of specific HMO profiles to address varying nutritional needs. The regulatory landscape surrounding infant nutrition is evolving to accommodate the inclusion of HMOs in commercial products.
Brazil has a substantial market for infant formula, driven by factors such as changing lifestyles, working mothers, and the convenience of formula feeding. As manufacturers seek to enhance the nutritional content of formula, the incorporation of HMOs has gained traction. Like in many other regions, parents in Brazil are increasingly seeking formula options that offer additional health benefits, and HMO-enriched formulas address this demand. Collaborations between HMO manufacturers, formula producers, and research institutions contribute to the innovation in formula formulations. This collaboration leads to the development of products that meet the nutritional needs of infants. These aspects will boost market growth in the coming years.
The Brazil market dominated the LAMEA Human Milk Oligosaccharides Market, by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $20,544 Thousand by 2030, growing at a CAGR of 24.2 % during the forecast period. The Argentina market is showcasing a CAGR of 26.2% during (2023 - 2030). Additionally, The UAE market would register a CAGR of 25.2% during (2023 - 2030).
Based on Application, the market is segmented into Infant Formula, Functional Food & Beverages, Food Supplements, and Others (Clinical Nutrition & Pharmaceuticals). Based on Type, the market is segmented into 2'FL, 3'FL, 3'SL, and 6'SL. Based on Concentration, the market is segmented into Neutral, and Acidic. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
Free Valuable Insights: The Worldwide Human Milk Oligosaccharides Market is Projected to reach USD 1 Billion by 2030, at a CAGR of 23.3%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Koninklijke DSM N.V., BASF SE, Chr. Hansen Holding A/S, DuPont de Nemours, Inc., Nestle S.A, Inbiose NV, Biosynth AG, Abbott Laboratories, Royal FrieslandCampina N.V. and Dextra Laboratories Ltd (ICE S.p.A).
Scope of the Study
Market Segments Covered in the Report:
By Application
- Infant Formula
- Functional Food & Beverages
- Food Supplements
- Others (Clinical Nutrition & Pharmaceuticals)
By Type
By Concentration
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Koninklijke DSM N.V.
- BASF SE
- Chr.Hansen Holding A/S
- DuPont de Nemours, Inc.
- Nestle S.A
- Inbiose NV
- Biosynth AG
- Abbott Laboratories
- Royal FrieslandCampina N.V.
- Dextra Laboratories Ltd (ICE S.p.A)
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Human Milk Oligosaccharides Market, by Application
1.4.2 LAMEA Human Milk Oligosaccharides Market, by Type
1.4.3 LAMEA Human Milk Oligosaccharides Market, by Concentration
1.4.4 LAMEA Human Milk Oligosaccharides Market, by Country
1.5 Methodology for the research
Chapter 2. Market At a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
Chapter 4. Competition Analysis - Global
4.1 KBV Cardinal Matrix
4.2 Recent Industry Wide Strategic Developments
4.2.1 Partnerships, Collaborations and Agreements
4.2.2 Product Launches and Product Expansions
4.2.3 Acquisition and Mergers
4.2.4 Trials and Approvals
4.3 Top Winning Strategies
4.3.1 Key Leading Strategies: Percentage Distribution (2019-2023)
4.4 Porter Five Forces Analysis
Chapter 5. LAMEA Human Milk Oligosaccharides Market, by Application
5.1 LAMEA Infant Formula Market, by Country
5.2 LAMEA Functional Food & Beverages Market, by Country
5.3 LAMEA Food Supplements Market, by Country
5.4 LAMEA Others (Clinical Nutrition & Pharmaceuticals) Market, by Country
Chapter 6. LAMEA Human Milk Oligosaccharides Market, by Type
6.1 LAMEA 2'FL Market, by Country
6.2 LAMEA 3'FL Market, by Country
6.3 LAMEA 3'SL Market, by Country
6.4 LAMEA 6'SL Market, by Country
Chapter 7. LAMEA Human Milk Oligosaccharides Market, by Concentration
7.1 LAMEA Neutral Market, by Country
7.2 LAMEA Acidic Market, by Country
Chapter 8. LAMEA Human Milk Oligosaccharides Market, by Country
8.1 Brazil Human Milk Oligosaccharides Market
8.1.1 Brazil Human Milk Oligosaccharides Market, by Application
8.1.2 Brazil Human Milk Oligosaccharides Market, by Type
8.1.3 Brazil Human Milk Oligosaccharides Market, by Concentration
8.2 Argentina Human Milk Oligosaccharides Market
8.2.1 Argentina Human Milk Oligosaccharides Market, by Application
8.2.2 Argentina Human Milk Oligosaccharides Market, by Type
8.2.3 Argentina Human Milk Oligosaccharides Market, by Concentration
8.3 UAE Human Milk Oligosaccharides Market
8.3.1 UAE Human Milk Oligosaccharides Market, by Application
8.3.2 UAE Human Milk Oligosaccharides Market, by Type
8.3.3 UAE Human Milk Oligosaccharides Market, by Concentration
8.4 Saudi Arabia Human Milk Oligosaccharides Market
8.4.1 Saudi Arabia Human Milk Oligosaccharides Market, by Application
8.4.2 Saudi Arabia Human Milk Oligosaccharides Market, by Type
8.4.3 Saudi Arabia Human Milk Oligosaccharides Market, by Concentration
8.5 South Africa Human Milk Oligosaccharides Market
8.5.1 South Africa Human Milk Oligosaccharides Market, by Application
8.5.2 South Africa Human Milk Oligosaccharides Market, by Type
8.5.3 South Africa Human Milk Oligosaccharides Market, by Concentration
8.6 Nigeria Human Milk Oligosaccharides Market
8.6.1 Nigeria Human Milk Oligosaccharides Market, by Application
8.6.2 Nigeria Human Milk Oligosaccharides Market, by Type
8.6.3 Nigeria Human Milk Oligosaccharides Market, by Concentration
8.7 Rest of LAMEA Human Milk Oligosaccharides Market
8.7.1 Rest of LAMEA Human Milk Oligosaccharides Market, by Application
8.7.2 Rest of LAMEA Human Milk Oligosaccharides Market, by Type
8.7.3 Rest of LAMEA Human Milk Oligosaccharides Market, by Concentration
Chapter 9. Company Profiles
9.1 Inbiose NV
9.1.1 Company Overview
9.1.2 SWOT Analysis
9.2 Biosynth AG
9.2.1 Company Overview
9.2.2 SWOT Analysis
9.3 Dextra Laboratories Ltd (ICE S.p.A)
9.3.1 Company Overview
9.4 Koninklijke DSM N.V.
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.4.4 Research & Development Expense
9.4.5 Recent strategies and developments:
9.4.5.1 Trials and Approvals:
9.4.5.2 Acquisition and Mergers:
9.4.6 SWOT Analysis
9.5 BASF SE
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expense
9.5.5 Recent strategies and developments:
9.5.5.1 Partnerships, Collaborations, and Agreements:
9.5.5.2 Product Launches and Product Expansions:
9.5.1 SWOT Analysis
9.6 Chr. Hansen Holding A/S
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Segment & Regional Analysis
9.6.4 Research & Development Expense
9.6.5 Recent strategies and developments:
9.6.5.1 Trials and Approvals:
9.6.5.2 Acquisition and Mergers:
9.7 DuPont de Nemours, Inc.
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expense
9.7.5 Recent strategies and developments:
9.7.5.1 Partnerships, Collaborations, and Agreements:
9.7.6 SWOT Analysis
9.8 Nestle S.A
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Segmental and Regional Analysis
9.8.4 Research & Development Expenses
9.8.5 Recent strategies and developments:
9.8.5.1 Product Launches and Product Expansions:
9.8.6 SWOT Analysis
9.9 Abbott Laboratories
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Segmental and Regional Analysis
9.9.4 Research & Development Expense
9.9.5 Recent strategies and developments:
9.9.5.1 Product Launches and Product Expansions:
9.9.6 SWOT Analysis
9.10. Royal FrieslandCampina N.V.
9.10.1 Company Overview
9.10.2 Financial Analysis
9.10.3 Segmental and Regional Analysis
9.10.4 Research & Development Expenses
9.10.5 Recent strategies and developments:
9.10.5.1 Partnerships, Collaborations, and Agreements:
9.10.5.2 Trials and Approvals:
9.10.6 SWOT Analysis
TABLE 1 LAMEA Human Milk Oligosaccharides Market, 2019 - 2022, USD Thousand
TABLE 2 LAMEA Human Milk Oligosaccharides Market, 2023 - 2030, USD Thousand
TABLE 3 Partnerships, Collaborations and Agreements– Human Milk Oligosaccharides Market
TABLE 4 Product Launches And Product Expansions– Human Milk Oligosaccharides Market
TABLE 5 Acquisition and Mergers– Human Milk Oligosaccharides Market
TABLE 6 Trials and Approvals- Human Milk Oligosaccharides Market
TABLE 7 LAMEA Human Milk Oligosaccharides Market, by Application, 2019 - 2022, USD Thousand
TABLE 8 LAMEA Human Milk Oligosaccharides Market, by Application, 2023 - 2030, USD Thousand
TABLE 9 LAMEA Infant Formula Market, by Country, 2019 - 2022, USD Thousand
TABLE 10 LAMEA Infant Formula Market, by Country, 2023 - 2030, USD Thousand
TABLE 11 LAMEA Functional Food & Beverages Market, by Country, 2019 - 2022, USD Thousand
TABLE 12 LAMEA Functional Food & Beverages Market, by Country, 2023 - 2030, USD Thousand
TABLE 13 LAMEA Food Supplements Market, by Country, 2019 - 2022, USD Thousand
TABLE 14 LAMEA Food Supplements Market, by Country, 2023 - 2030, USD Thousand
TABLE 15 LAMEA Others (Clinical Nutrition & Pharmaceuticals) Market, by Country, 2019 - 2022, USD Thousand
TABLE 16 LAMEA Others (Clinical Nutrition & Pharmaceuticals) Market, by Country, 2023 - 2030, USD Thousand
TABLE 17 LAMEA Human Milk Oligosaccharides Market, by Type, 2019 - 2022, USD Thousand
TABLE 18 LAMEA Human Milk Oligosaccharides Market, by Type, 2023 - 2030, USD Thousand
TABLE 19 LAMEA 2'FL Market, by Country, 2019 - 2022, USD Thousand
TABLE 20 LAMEA 2'FL Market, by Country, 2023 - 2030, USD Thousand
TABLE 21 LAMEA 3'FL Market, by Country, 2019 - 2022, USD Thousand
TABLE 22 LAMEA 3'FL Market, by Country, 2023 - 2030, USD Thousand
TABLE 23 LAMEA 3'SL Market, by Country, 2019 - 2022, USD Thousand
TABLE 24 LAMEA 3'SL Market, by Country, 2023 - 2030, USD Thousand
TABLE 25 LAMEA 6'SL Market, by Country, 2019 - 2022, USD Thousand
TABLE 26 LAMEA 6'SL Market, by Country, 2023 - 2030, USD Thousand
TABLE 27 LAMEA Human Milk Oligosaccharides Market, by Concentration, 2019 - 2022, USD Thousand
TABLE 28 LAMEA Human Milk Oligosaccharides Market, by Concentration, 2023 - 2030, USD Thousand
TABLE 29 LAMEA Neutral Market, by Country, 2019 - 2022, USD Thousand
TABLE 30 LAMEA Neutral Market, by Country, 2023 - 2030, USD Thousand
TABLE 31 LAMEA Acidic Market, by Country, 2019 - 2022, USD Thousand
TABLE 32 LAMEA Acidic Market, by Country, 2023 - 2030, USD Thousand
TABLE 33 LAMEA Human Milk Oligosaccharides Market, by Country, 2019 - 2022, USD Thousand
TABLE 34 LAMEA Human Milk Oligosaccharides Market, by Country, 2023 - 2030, USD Thousand
TABLE 35 Brazil Human Milk Oligosaccharides Market, 2019 - 2022, USD Thousand
TABLE 36 Brazil Human Milk Oligosaccharides Market, 2023 - 2030, USD Thousand
TABLE 37 Brazil Human Milk Oligosaccharides Market, by Application, 2019 - 2022, USD Thousand
TABLE 38 Brazil Human Milk Oligosaccharides Market, by Application, 2023 - 2030, USD Thousand
TABLE 39 Brazil Human Milk Oligosaccharides Market, by Type, 2019 - 2022, USD Thousand
TABLE 40 Brazil Human Milk Oligosaccharides Market, by Type, 2023 - 2030, USD Thousand
TABLE 41 Brazil Human Milk Oligosaccharides Market, by Concentration, 2019 - 2022, USD Thousand
TABLE 42 Brazil Human Milk Oligosaccharides Market, by Concentration, 2023 - 2030, USD Thousand
TABLE 43 Argentina Human Milk Oligosaccharides Market, 2019 - 2022, USD Thousand
TABLE 44 Argentina Human Milk Oligosaccharides Market, 2023 - 2030, USD Thousand
TABLE 45 Argentina Human Milk Oligosaccharides Market, by Application, 2019 - 2022, USD Thousand
TABLE 46 Argentina Human Milk Oligosaccharides Market, by Application, 2023 - 2030, USD Thousand
TABLE 47 Argentina Human Milk Oligosaccharides Market, by Type, 2019 - 2022, USD Thousand
TABLE 48 Argentina Human Milk Oligosaccharides Market, by Type, 2023 - 2030, USD Thousand
TABLE 49 Argentina Human Milk Oligosaccharides Market, by Concentration, 2019 - 2022, USD Thousand
TABLE 50 Argentina Human Milk Oligosaccharides Market, by Concentration, 2023 - 2030, USD Thousand
TABLE 51 UAE Human Milk Oligosaccharides Market, 2019 - 2022, USD Thousand
TABLE 52 UAE Human Milk Oligosaccharides Market, 2023 - 2030, USD Thousand
TABLE 53 UAE Human Milk Oligosaccharides Market, by Application, 2019 - 2022, USD Thousand
TABLE 54 UAE Human Milk Oligosaccharides Market, by Application, 2023 - 2030, USD Thousand
TABLE 55 UAE Human Milk Oligosaccharides Market, by Type, 2019 - 2022, USD Thousand
TABLE 56 UAE Human Milk Oligosaccharides Market, by Type, 2023 - 2030, USD Thousand
TABLE 57 UAE Human Milk Oligosaccharides Market, by Concentration, 2019 - 2022, USD Thousand
TABLE 58 UAE Human Milk Oligosaccharides Market, by Concentration, 2023 - 2030, USD Thousand
TABLE 59 Saudi Arabia Human Milk Oligosaccharides Market, 2019 - 2022, USD Thousand
TABLE 60 Saudi Arabia Human Milk Oligosaccharides Market, 2023 - 2030, USD Thousand
TABLE 61 Saudi Arabia Human Milk Oligosaccharides Market, by Application, 2019 - 2022, USD Thousand
TABLE 62 Saudi Arabia Human Milk Oligosaccharides Market, by Application, 2023 - 2030, USD Thousand
TABLE 63 Saudi Arabia Human Milk Oligosaccharides Market, by Type, 2019 - 2022, USD Thousand
TABLE 64 Saudi Arabia Human Milk Oligosaccharides Market, by Type, 2023 - 2030, USD Thousand
TABLE 65 Saudi Arabia Human Milk Oligosaccharides Market, by Concentration, 2019 - 2022, USD Thousand
TABLE 66 Saudi Arabia Human Milk Oligosaccharides Market, by Concentration, 2023 - 2030, USD Thousand
TABLE 67 South Africa Human Milk Oligosaccharides Market, 2019 - 2022, USD Thousand
TABLE 68 South Africa Human Milk Oligosaccharides Market, 2023 - 2030, USD Thousand
TABLE 69 South Africa Human Milk Oligosaccharides Market, by Application, 2019 - 2022, USD Thousand
TABLE 70 South Africa Human Milk Oligosaccharides Market, by Application, 2023 - 2030, USD Thousand
TABLE 71 South Africa Human Milk Oligosaccharides Market, by Type, 2019 - 2022, USD Thousand
TABLE 72 South Africa Human Milk Oligosaccharides Market, by Type, 2023 - 2030, USD Thousand
TABLE 73 South Africa Human Milk Oligosaccharides Market, by Concentration, 2019 - 2022, USD Thousand
TABLE 74 South Africa Human Milk Oligosaccharides Market, by Concentration, 2023 - 2030, USD Thousand
TABLE 75 Nigeria Human Milk Oligosaccharides Market, 2019 - 2022, USD Thousand
TABLE 76 Nigeria Human Milk Oligosaccharides Market, 2023 - 2030, USD Thousand
TABLE 77 Nigeria Human Milk Oligosaccharides Market, by Application, 2019 - 2022, USD Thousand
TABLE 78 Nigeria Human Milk Oligosaccharides Market, by Application, 2023 - 2030, USD Thousand
TABLE 79 Nigeria Human Milk Oligosaccharides Market, by Type, 2019 - 2022, USD Thousand
TABLE 80 Nigeria Human Milk Oligosaccharides Market, by Type, 2023 - 2030, USD Thousand
TABLE 81 Nigeria Human Milk Oligosaccharides Market, by Concentration, 2019 - 2022, USD Thousand
TABLE 82 Nigeria Human Milk Oligosaccharides Market, by Concentration, 2023 - 2030, USD Thousand
TABLE 83 Rest of LAMEA Human Milk Oligosaccharides Market, 2019 - 2022, USD Thousand
TABLE 84 Rest of LAMEA Human Milk Oligosaccharides Market, 2023 - 2030, USD Thousand
TABLE 85 Rest of LAMEA Human Milk Oligosaccharides Market, by Application, 2019 - 2022, USD Thousand
TABLE 86 Rest of LAMEA Human Milk Oligosaccharides Market, by Application, 2023 - 2030, USD Thousand
TABLE 87 Rest of LAMEA Human Milk Oligosaccharides Market, by Type, 2019 - 2022, USD Thousand
TABLE 88 Rest of LAMEA Human Milk Oligosaccharides Market, by Type, 2023 - 2030, USD Thousand
TABLE 89 Rest of LAMEA Human Milk Oligosaccharides Market, by Concentration, 2019 - 2022, USD Thousand
TABLE 90 Rest of LAMEA Human Milk Oligosaccharides Market, by Concentration, 2023 - 2030, USD Thousand
TABLE 91 Key Information – Inbiose NV
TABLE 92 Key Information – Biosynth AG
TABLE 93 Key Information – Dextra Laboratories Ltd
TABLE 94 Key Information – Koninklijke DSM N.V.
TABLE 95 Key Information – BASF SE
TABLE 96 Key Information – Chr. Hansen Holding A/S
TABLE 97 Key Information –DuPont de Nemours, Inc.
TABLE 98 Key Information – Nestle S.A
TABLE 99 Key Information – Abbott Laboratories
TABLE 100 Key Information – Royal FrieslandCampina N.V.
List of Figures
FIG 1 Methodology for the research
FIG 2 LAMEA Human Milk Oligosaccharides Market, 2019 - 2030, USD Thousand
FIG 3 Key Factors Impacting the Human Milk Oligosaccharides Market
FIG 4 KBV Cardinal Matrix
FIG 5 Key Leading Strategies: Percentage Distribution (2019-2023)
FIG 6 Porter’s Five Forces Analysis – Human Milk Oligosaccharides Market
FIG 7 LAMEA Human Milk Oligosaccharides Market, Share by Application, 2022
FIG 8 LAMEA Human Milk Oligosaccharides Market, Share by Application, 2030
FIG 9 LAMEA Human Milk Oligosaccharides Market, by Application, 2019 - 2030, USD Thousand
FIG 10 LAMEA Human Milk Oligosaccharides Market, Share by Type, 2022
FIG 11 LAMEA Human Milk Oligosaccharides Market, Share by Type, 2030
FIG 12 LAMEA Human Milk Oligosaccharides Market, by Type, 2019 - 2030, USD Thousand
FIG 13 LAMEA Human Milk Oligosaccharides Market, Share by Concentration, 2022
FIG 14 LAMEA Human Milk Oligosaccharides Market, Share by Concentration, 2030
FIG 15 LAMEA Human Milk Oligosaccharides Market, by Concentration, 2019 - 2030, USD Thousand
FIG 16 LAMEA Human Milk Oligosaccharides Market, Share by Country, 2022
FIG 17 LAMEA Human Milk Oligosaccharides Market, Share by Country, 2030
FIG 18 LAMEA Human Milk Oligosaccharides Market, by Country, 2019 - 2030, USD Thousand
FIG 19 SWOT Analysis: Inbiose NV
FIG 20 SWOT Analysis: Biosynth AG
FIG 21 SWOT Analysis: Koninklijke DSM N.V.
FIG 22 Recent strategies and developments: BASF SE
FIG 23 SWOT Analysis: BASF SE
FIG 24 SWOT Analysis: DuPont de Nemours, Inc.
FIG 25 SWOT Analysis: Nestle S.A
FIG 26 SWOT Analysis: Abbott Laboratories
FIG 27 Recent strategies and developments: Royal FrieslandCampina N.V.
FIG 28 SWOT Analysis: Royal FrieslandCampina N.V.